22-hydroxycholesterol has been researched along with gw9662 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alegret, M; Ciudad, CJ; Laguna, JC; Llaverias, G; Noé, V; Sánchez, RM; Vázquez-Carrera, M | 1 |
| Lee, SJ; Shin, JG; Yi, M | 1 |
2 other study(ies) available for 22-hydroxycholesterol and gw9662
| Article | Year |
|---|---|
Rosiglitazone upregulates caveolin-1 expression in THP-1 cells through a PPAR-dependent mechanism.
Topics: Anilides; Animals; Apoptosis; Base Sequence; Binding Sites; Blotting, Western; Caspase 3; Caspases; Caveolin 1; Caveolins; CD11b Antigen; Cell Line; DNA-Binding Proteins; Dose-Response Relationship, Drug; Flow Cytometry; Humans; Hydroxycholesterols; Ligands; Liver X Receptors; Macrophages; Molecular Sequence Data; Orphan Nuclear Receptors; PPAR gamma; Promoter Regions, Genetic; Protein Biosynthesis; Rats; Receptors, Cytoplasmic and Nuclear; RNA; RNA, Messenger; Rosiglitazone; Tetradecanoylphorbol Acetate; Thiazolidinediones; Time Factors; Transcription, Genetic; Up-Regulation; Vasodilator Agents | 2004 |
Expression of CYP4V2 in human THP1 macrophages and its transcriptional regulation by peroxisome proliferator-activated receptor gamma.
Topics: Anilides; Cell Line; Cytochrome P450 Family 4; Fatty Acids; Gene Expression Regulation, Enzymologic; Humans; Hydroxycholesterols; Lauric Acids; Liver X Receptors; Macrophages; PPAR alpha; RNA, Messenger; RNA, Small Interfering; Tetradecanoylphorbol Acetate; Transcription, Genetic | 2017 |